Role of C5 Activation Products in Sepsis
Complement activation products are known to be generated in the setting of both experimental and human sepsis. C5 activation products (C5a anaphylatoxin and the membrane attack complex [MAC] C5b-9) are generated during sepsis following infusion of endotoxin, or after cecal ligation and puncture (CLP...
Saved in:
Main Author: | Peter A. Ward |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2010-01-01
|
Series: | The Scientific World Journal |
Online Access: | http://dx.doi.org/10.1100/tsw.2010.216 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Manipulation of the Complement System for Benefit in Sepsis
by: Peter A. Ward, et al.
Published: (2012-01-01) -
C5a/C5aR regulates Th1/Th2 imbalance in sepsis-associated lung injury by promoting neutrophil activation to increase PAD4 expression
by: Zhenbing Lu, et al.
Published: (2025-12-01) -
Understanding the Difficulties in Diagnosing Neonatal Sepsis: Assessing the Role of Sepsis Biomarkers
by: Lungu Nicoleta, et al.
Published: (2024-10-01) -
The role of natural products targeting macrophage polarization in sepsis-induced lung injury
by: Yake Li, et al.
Published: (2025-02-01) -
The role of high-density lipoproteins in sepsis
by: Liam R. Brunham
Published: (2025-01-01)